QUOTE AND NEWS
Clusterstock  May 15  Comment 
Attorney General Eric Holder is testifying in front of Congress today . Not surprisingly, he is being asked about the Justice Department's obtaining Associated Press phone records without telling the Associated Press in advance. As I...
MarketWatch  May 7  Comment 
Demand Media Inc. on Tuesday reported a first-quarter profit of $700,000, or a penny a share, on revenue excluding traffic-acquisition costs of $95.2 million. During the year-ago period, the provider of digital media content and services lost...
StreetInsider.com  May 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Demand+Media+%28DMD%29+Posts+Q1+EPS+of+9c%3B+Issues+Mixed+Q2+Outlook%3B+Guides+FY13/8313866.html for the full story.
TheStreet.com  Apr 26  Comment 
KINGSTON, Mass. (TheStreet) -- While there seems to be a debate related to the dystrophin being produced by eteplirsen and whether or not it has proven to be correlated with a clinical benefit, I believe the FDA guidance on accelerated approval...
TheStreet.com  Apr 25  Comment 
NEW YORK (TheStreet) -- It's been a little over a week since Sarepta Therapeutics announced the FDA asked for more information before deciding on whether or not to allow the company to seek accelerated approval for eteplirsen in Duchenne muscular...
Benzinga  Apr 15  Comment 
Sarepta Therapeutics (NASDAQ: SRPT) today provided an update on its discussions with the U.S. Food and Drug Administration (FDA) regarding a potential application for accelerated approval of eteplirsen for the treatment of Duchenne muscular...
TheStreet.com  Apr 12  Comment 
NEW YORK (TheStreet) -- I spent a lot of time last night examining the efficacy curves depicted in the photo posted above. This is the money shot from Thursday's presentation by GlaxoSmithKline of the first placebo-controlled data on its Duchenne...
StreetInsider.com  Apr 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sarepta+%28SRPT%29%2C+UWA+Enter+DMD+Drug+Candidate+Development+Agreement/8247164.html for the full story.
Benzinga  Apr 11  Comment 
Sarepta Therapeutics (NASDAQ: SRPT) and the University of Western Australia (UWA) today announced that they have entered into an exclusive, worldwide licensing agreement for intellectual property rights to support the development of exon-skipping...
FierceBiotech  Apr 10  Comment 
After keeping its mid-stage data for a closely-watched and controversial drug for Duchenne muscular dystrophy (DMD) under wraps, GlaxoSmithKline ($GSK) has pulled back part of the covers to reveal that drisapersen did in fact hit the primary...




 
TOP CONTRIBUTORS

Demand Media (NYSE:DMD) is an internet based company which creates and monetizes on web content. The company focuses on entering subject areas with existing interest and generating high quality content to fulfill the interest. It then sells advertisement space and helps the advertisers to distribute and optimize their campaigns.[1] Demand Media provides advertisers access to the growing online advertising market in the United States by taking advantage of existing areas of interest and providing unified, high quality, and search-engine optimized content.[2]

The company operates two distinct services: Content & Media and Registrar. The Content & Media segment identifies existing areas of interest in internet content. It then creates and distributes this content with a focus on search-engine optimization. It also builds social media applications which can be purchased as features by third party websites. Finally, it delivers and optimizes advertisements targeted to customers. The Content & Media segment owns a collection of sites which make up the 17th largest web property in the US and attracts approximately 105M unique views per month.The Registrar segment manages internet domain names and is the world's largest wholesale registrar. This segment offers customers the ability to register a domain name as well as subscribe to extra value-added services.[3]

The company's initial public offering of stock on the NYSE occurred on January 25, 2011. The company offered 8.9M shares each for $17. This was above the initial price range of $14-$16, and the initial offer size of 7.5M. This brought the total deal size to $151M, while the deal was originally expected at $112.5M at the center of the price range. The lead underwriters of the IPO were Goldman and Morgan Stanley (MS).[4]

In 2009, Demand Media reported a total annual revenue of $198M. This was a 16% increase over the 2008 figure of $170M. During the first 9 months of 2010, the company reported a total revenue of $179M. This corresponds to a 25% increase over the $143M reported for the same period in 2009. However, in 2009, the company's net loss increase to $22M from a loss of $15M in 2008. During the first 9 months of 2010, the company's net loss was $6M, compared to $19M during the same period of 2009.[5]


References

  1. Demand Media S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg1
  2. Demand Media S-1/A 2011 PROSPECTUS SUMMARY "Industry Background" pg2
  3. Demand Media S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg1-2
  4. Renaissance Capital - IPO Home "Demand Media prices IPO at $17, above the range; largest Internet IPO since Google" 25 Jan 2010
  5. Demand Media S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg1-2
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki